Chapter 7

Calcium Deregulation in Alzheimer’s Disease

Vitor S. Alves, Fernanda L. Ribeiro, Daniela R. de Oliveira and Fernando A. Oliveira

Abstract

The first ideas proposed by Zaven Khachaturian about the calcium (Ca2+) hypothesis of brain aging foster researchers into cellular and molecular mechanisms trying to explain Ca2+ alterations of brain function and cognitive deficits. Alzheimer’s disease (AD) is dementia causally linked to aging, therefore Ca2+ cellular processes underlying aging-related impairments in the brain may share similarities to severe dementia, as in AD. The effective control of cytosolic Ca2+ is essential for the modulation of various processes and pathways of neuronal signaling, and its inefficiency or deregulation can lead to austere pathological conditions. This chapter shows pieces of evidence of Ca2+ deregulation in AD and its consequences, focusing on intrinsic properties of the neurons.

Total Pages: 202-215 (14)

Purchase Chapter  Book Details

RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Alzheimer
.Advances in Alzheimer Research.